Benztropine Mesylate Injection Shortage
Last Updated: April 9, 2021
Status: Resolved
Reason for the Shortage
-
- Akorn is not marketing benztropine 1 mg/mL 2 mL ampules and Cogentin 1 mg/mL 2 mL ampules.
- Fresenius Kabi did not provide a reason for the shortage.
- Hikma did not provide a reason for the shortage.
Available Products
-
- Benztropine Mesylate injection, Fresenius Kabi, 1 mg/mL, 2 mL vial, 5 count, NDC 63323-0970-02
- Benztropine Mesylate injection, Hikma, 1 mg/mL, 2 mL ampule, 5 count, NDC 00143-9729-05
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated April 9, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 30, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.